Huang, Z., Yang, X., Jin, Y., Yu, J., Cao, G., Wang, J., . . . Wu, X. (2024). First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects. Antimicrobial agents and chemotherapy, 68(1), e0133023. https://doi.org/10.1128/aac.01330-23
Chicago Style (17th ed.) CitationHuang, Zhiwei, et al. "First-in-human Study to Evaluate the Safety, Tolerability, and Population Pharmacokinetic/pharmacodynamic Target Attainment Analysis of FL058 Alone and in Combination with Meropenem in Healthy Subjects." Antimicrobial Agents and Chemotherapy 68, no. 1 (2024): e0133023. https://doi.org/10.1128/aac.01330-23.
MLA (9th ed.) CitationHuang, Zhiwei, et al. "First-in-human Study to Evaluate the Safety, Tolerability, and Population Pharmacokinetic/pharmacodynamic Target Attainment Analysis of FL058 Alone and in Combination with Meropenem in Healthy Subjects." Antimicrobial Agents and Chemotherapy, vol. 68, no. 1, 2024, p. e0133023, https://doi.org/10.1128/aac.01330-23.